0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

CONTROLLED TRIAL OF METHOXSALEN IN SOLAR DERMATITIS OF CHIPPEWA INDIANS

Robert R. Schenck, M.D.
JAMA. 1960;172(11):1134-1137. doi:10.1001/jama.1960.03020110018005.
Text Size: A A A
Published online

A markedly seasonal dermatitis, characterized by erythema, edema, vesiculation, and crusting, occurs among American Indians. The possibility of preventing it by administration of methoxsalen was studied in 13 members of a group of Chippewa Indians living in Minnesota. The course of the dermatitis during two-week periods of medication with methoxsalen was compared with its course during periods of placebo administration. The results showed that regardless of medication most patients improved under limited controlled exposure to sunlight whereas in outpatients methoxsalen, in a dosage of two 10-mg. capsules per day by mouth, caused a worsening of the condition in six of the nine patients evaluated. Lactose produced a variety of responses in 10 patients. Since the most important etiological factor in the dermatitis was exposure to sunlight, the wearing of wide-brimmed hats and other protective covering was advised as the logical method of prevention and treatment.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();